Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. B. Kaye
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
Science Translational Medicine
Medicine
The First-In-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls
Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-response in VHL−/−clear Cell Renal Carcinoma
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Inhibiting the Inhibitors, PTP1B as a Therapeutic Target in Myocardial Infarction
Heart Research - Open Journal
Wogonin Inhibits Multiple Myeloma-Stimulated Angiogenesis via C-Myc/VHL/HIF-1α Signaling Axis
Oncotarget
Oncology
Mp60-09 Lim1 Oncogene as a New Therapeutic Target in Advanced Human Renal Cell Carcinoma
Journal of Urology
Urology
Survivin Is a Therapeutic Target in Merkel Cell Carcinoma
Science Translational Medicine
Medicine
Insights Into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma
Cancer Discovery
Oncology
VHL Loss Predicts Response to Aurora Kinase a Inhibitor in Renal Cell Carcinoma Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via SRC-Rac1 Signaling Axis
Frontiers in Oncology
Cancer Research
Oncology
